Filter Results

Clear All Filters

Displaying 7 results for

GO
Search Filters: Maggie Davis cancel Hawaii cancel State Health Policy cancel

2022 Legislative Session Update: Part Two

Blog,
STIs,
HIV,
PFAS,

The ASTHO State Health Policy team provides brief updates on 5 of the ten state health policy issues to watch in 2022: mental and behavioral health, rural health, e-cigarettes and flavored tobacco products, HIV and PFAS.

Domestic Holiday Travel Pandemic Restrictions and Recommendations

Blog,
Guam,
Iowa,
Ohio,
Utah,

The 2020 holiday season is coinciding with a nationwide surge of COVID-19 cases. With great concern that holiday travel to see loved ones may exacerbate community spread of the virus, many states are increasing public health measures ...

ASTHO Policy Watch 2022: Mental Health

Blog,
Ohio,

Continuing ASTHO’s Legislative Prospectus series—which highlights the top 10 public health policy issues for 2022—this post focuses on mental and behavioral health, as well as supporting the public health workforce.

More States Consider Restricting Sale of Flavored Tobacco Products

Blog,

A pressing public health issue before the COVID-19 pandemic hit, the need for public health interventions to reduce tobacco use is heightened with a strong association between tobacco use, in all forms, with severe COVID-19 outcomes. ...

State and Territorial Policies to Strengthen the Public Health and Healthcare Workforce

Blog,

Accompanying an infusion of federal funding, states are considering several policy changes to strengthen the public health workforce and address challenges within the health care workforce.

States Stepping Up to Support Families and Reduce Adverse Childhood Experiences

Blog,
ACEs,

Research confirms that strengthening economic supports can improve parental mental health, children’s health, education, and social outcomes.

2023 Legislative Session Update: Part One

Blog,
STIs,
HIV,
PFAS,
Guam,
Utah,

A mid-session legislative update on five of ASTHO's top 10 public health state policy issues to watch in 2023: tobacco, HIV, mental health, PFAS, and opioids.